| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.551 | 6.944 | 6.285 | 7.924 | 11.234 | 12.676 | 17.991 |
| Total Income - EUR | - | - | - | 4.554 | 6.944 | 6.285 | 7.924 | 11.234 | 12.676 | 17.992 |
| Total Expenses - EUR | - | - | - | 439 | 825 | 860 | 938 | 1.361 | 2.034 | 1.399 |
| Gross Profit/Loss - EUR | - | - | - | 4.115 | 6.118 | 5.425 | 6.986 | 9.873 | 10.641 | 16.594 |
| Net Profit/Loss - EUR | - | - | - | 3.979 | 5.910 | 5.242 | 6.777 | 9.536 | 8.938 | 13.992 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sandu Raluca Neuro Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 37 | 36 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 4.127 | 10.157 | 15.618 | 22.545 | 9.685 | 10.264 | 21.756 |
| Inventories | - | - | - | 0 | 207 | 424 | 415 | 694 | 0 | 0 |
| Receivables | - | - | - | 387 | 0 | 517 | 788 | 811 | 1.264 | 15.258 |
| Cash | - | - | - | 3.740 | 9.950 | 14.677 | 21.342 | 8.180 | 9.001 | 6.497 |
| Shareholders Funds | - | - | - | 4.021 | 9.853 | 14.908 | 21.354 | 9.585 | 9.704 | 14.040 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 142 | 340 | 710 | 1.190 | 100 | 561 | 7.716 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sandu Raluca Neuro Med S.r.l.